These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10669006)

  • 1. Morphologic characterization of spontaneous nervous system tumors in mice and rats.
    Krinke GJ; Kaufmann W; Mahrous AT; Schaetti P
    Toxicol Pathol; 2000; 28(1):178-92. PubMed ID: 10669006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
    Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
    J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system.
    Adamson DC; Rasheed BA; McLendon RE; Bigner DD
    Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural pathology of glial brain tumors revisited: a review.
    Liberski PP; Kordek R
    Ultrastruct Pathol; 1997; 21(1):1-31. PubMed ID: 9029763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumors of the nervous system in carcinogenic hazard identification.
    Rice JM; Wilbourn JD
    Toxicol Pathol; 2000; 28(1):202-14. PubMed ID: 10669008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of spontaneous and acrylonitrile-induced brain tumors in the rat.
    Kolenda-Roberts HM; Harris N; Singletary E; Hardisty JF
    Toxicol Pathol; 2013 Jan; 41(1):98-108. PubMed ID: 22821367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of rat central and peripheral nerve tumors induced by ethylnitrosourea.
    Raju NR; Yaeger MJ; Okazaki DL; Lovell K; Koestner A
    Toxicol Pathol; 1990; 18(1 Pt 1):18-23. PubMed ID: 1694597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of N-nitrosourea-induced tumors of the nervous system; their prospective value for studies of neurocarcinogenesis and brain tumor therapy.
    Koestner A
    Toxicol Pathol; 1990; 18(1 Pt 2):186-92. PubMed ID: 2195638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
    Lyons SA; O'Neal J; Sontheimer H
    Glia; 2002 Aug; 39(2):162-73. PubMed ID: 12112367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
    Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
    Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumors in S100beta-v-erbB transgenic rats.
    Ohgaki H; Kita D; Favereaux A; Huang H; Homma T; Dessen P; Weiss WA; Kleihues P; Heppner FL
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1111-7. PubMed ID: 17146284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primitive neuroectodermal tumors of the central nervous system.
    Becker LE; Hinton D
    Hum Pathol; 1983 Jun; 14(6):538-50. PubMed ID: 6303940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular aspects of neurocarcinogenesis.
    Kleihues P; Aguzzi A; Wiestler OD
    Toxicol Pathol; 1990; 18(1 Pt 2):193-203. PubMed ID: 2195639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse models of human cancer consortium symposium on nervous system tumors.
    Gutmann DH; Baker SJ; Giovannini M; Garbow J; Weiss W
    Cancer Res; 2003 Jun; 63(11):3001-4. PubMed ID: 12782610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of neural tumors in laboratory rodents, emphasizing the rat.
    Weber K; Garman RH; Germann PG; Hardisty JF; Krinke G; Millar P; Pardo ID
    Toxicol Pathol; 2011 Jan; 39(1):129-51. PubMed ID: 21196527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.